申请人:KATHOLIEKE UNIVERSITEIT LEUVEN, KU LEUVEN R&D
公开号:US20170022242A1
公开(公告)日:2017-01-26
The present invention relates to novel phosphate-modified nucleosides, such as phosphoramidate nucleosides. The invention also relates to the use of these novel phosphate-modified nucleosides to treat or prevent viral infections and proliferative diseases (such as cancer) and their use to manufacture a medicine to treat or prevent viral infections and proliferative diseases particularly infections with viruses belonging to the HCV family.